KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Equity Ratio (2009 - 2026)

Edwards Lifesciences' quarterly Equity Ratio came in at 0.78 in Q1 2026, down 0.94% year-on-year from 0.78 in Q1 2025, and up 2.72% quarter-over-quarter from 0.75 in Q4 2025.

Edwards Lifesciences has reported Equity Ratio for 18 years, with the latest figure at 0.78 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio fell 0.94% year-over-year to 0.78; the trailing twelve-month figure through Mar 2026 stood at 0.78 (down 0.94% YoY), and the FY2025 full-year result was 0.75, down 2.08% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.78, up from 0.75 in the prior quarter.
  • The five-year high for Equity Ratio was 0.79 in Q2 2025, with the low at 0.69 in Q1 2022.
  • Average Equity Ratio over 5 years is 0.74, with a median of 0.74 recorded in 2024.
  • Year-over-year, Equity Ratio increased 7.5% in 2022 and slipped 2.08% in 2025.
  • Tracing EW's Equity Ratio over 5 years: stood at 0.7 in 2022, then advanced by 2.49% to 0.72 in 2023, then gained by 7.41% to 0.77 in 2024, then dropped by 2.08% to 0.75 in 2025, then rose by 2.72% to 0.78 in 2026.
  • The last three Equity Ratio figures came in at 0.78 (Q1 2026), 0.75 (Q4 2025), and 0.77 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 0.56

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.78
Dec 31, 2025 0.75
Sep 30, 2025 0.77
Jun 30, 2025 0.79
Mar 31, 2025 0.78
Dec 31, 2024 0.77
Sep 30, 2024 0.74
Jun 30, 2024 0.74
Mar 31, 2024 0.74
Dec 31, 2023 0.72
Sep 30, 2023 0.72
Jun 30, 2023 0.72
Mar 31, 2023 0.70
Dec 31, 2022 0.70
Sep 30, 2022 0.72
Jun 30, 2022 0.71
Mar 31, 2022 0.69
Dec 31, 2021 0.69
Sep 30, 2021 0.68
Jun 30, 2021 0.67
Mar 31, 2021 0.65
Dec 31, 2020 0.63
Sep 30, 2020 0.62
Jun 30, 2020 0.60
Mar 31, 2020 0.64
Dec 31, 2019 0.64
Sep 30, 2019 0.64
Jun 30, 2019 0.63
Mar 31, 2019 0.63
Dec 31, 2018 0.59
Sep 30, 2018 0.56
Jun 30, 2018 0.56
Mar 31, 2018 0.56
Dec 31, 2017 0.52
Sep 30, 2017 0.58
Jun 30, 2017 0.57
Mar 31, 2017 0.57
Dec 31, 2016 0.58
Sep 30, 2016 0.62
Jun 30, 2016 0.61
Mar 31, 2016 0.60
Dec 31, 2015 0.62
Sep 30, 2015 0.62
Jun 30, 2015 0.63
Mar 31, 2015 0.63
Dec 31, 2014 0.62
Sep 30, 2014 0.61
Jun 30, 2014 0.58
Mar 31, 2014 0.51
Dec 31, 2013 0.57
Sep 30, 2013 0.57
Jun 30, 2013 0.68
Mar 31, 2013 0.69
Dec 31, 2012 0.66
Sep 30, 2012 0.70
Jun 30, 2012 0.69
Mar 31, 2012 0.69
Dec 31, 2011 0.67
Sep 30, 2011 0.68
Jun 30, 2011 0.69
Mar 31, 2011 0.70
Dec 31, 2010 0.74
Sep 30, 2010 0.71
Jun 30, 2010 0.68
Dec 31, 2009 0.72